The popular constipation prescription Zelnorm will no longer be available. Swiss drug maker Novartis has agreed to stop selling Zelnorm after it was linked to serious side effects including heart ...
ZURICH, March 30 (Reuters) - Novartis AG has pulled its bowel drug Zelnorm from the U.S. market at the request of regulators, after clinical trial data indicated a link to heart attacks and stroke.
NEW YORK, March 30 (Reuters) - The U.S. withdrawal of Novartis AG's Zelnorm treatment for irritable bowel syndrome highlights the sometimes narrow dividing line between success and failure in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results